Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Oropharyngeal Neoplasms 3 Carcinoma, Squamous Cell 2 Tongue Neoplasms 1 Thyroid Neoplasms 1 Radiation Injuries 1 Pain, Postoperative 1 Pain 1 Neoplasms 1 Neoplasm Metastasis 1 Mucositis 1 Mouth Neoplasms 1 Carcinoma 1

Interventions

Iodine-131 21 lenvatinib 17 Magnetic Resonance Spectroscopy 17 trametinib 13 Sorafenib 13 Thyrotropin Alfa 12 pembrolizumab 11 dabrafenib 11 Thyroidectomy 10 Surgical Procedures, Operative 10 Thyroxine 9 Paclitaxel 9 vandetanib 8 selpercatinib 8 Sunitinib 7 Nivolumab 7 Fluorodeoxyglucose F18 7 cabozantinib 6 anlotinib 6 Everolimus 6 Biopsy 6 pazopanib 5 Vemurafenib 5 Triiodothyronine 5 Specimen Handling 5 Saline Solution 5 Radiotherapy 5 Radiofrequency Ablation 5 Iodine-124 5 Cyclophosphamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Neck Dissection × Clear all

NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡